Evidence map›Paper›PMID 25999120›Full record

ReviewNeuroscience and biobehavioral reviews2015

Psychiatric disorders and leukocyte telomere length: Underlying mechanisms linking mental illness with cellular aging.

Daniel Lindqvist, Elissa S Epel, Synthia H Mellon, Brenda W Penninx, Dóra Révész, Josine E Verhoeven, Victor I Reus, Jue Lin, Laura Mahan, Christina M Hough and 4 more

2 registry-linked trialsAbstract readReview
In one paragraph

Review in Neuroscience and biobehavioral reviews, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 147 papers, 10 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
147citing papers in PubMed, 10 pooled it
21.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02592564 naunknown statusnot on this map

The Brain´s Plasticity and Change in Cellular Aging After Internet-delivered Cognitive Behavior Therapy for Social Anxiety Disorder

TypeinterventionalSponsorLinkoeping UniversityRan2015 to 2021Enrolled50ConditionsAnxiety Disorders, Social Anxiety DisorderArmsInternet-delivered cognitive behavior therapy
NCT03143075 nacompletednot on this mapstarted 2017, after this paper: background citation

Do Omega-3 Fatty Acids Have an Antidepressant Effect in Patients With Signs of Peripheral Inflammation?

TypeinterventionalSponsorRegion SkaneRan2017 to 2023Enrolled95ConditionsMajor Depressive DisorderArmsEicosapentaenoic acid enriched omega-3 fatty acids, 2 g/day
3 · Its place in the literature

Who cites it

147 citing papers in PubMed, 10 syntheses or guidelines pooled it, 286 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Meta-analysis of Telomere Length in Alzheimer's Disease.The journals of gerontology. Series A, Biological sciences and medical sciences · 2016
    Pooled it
  10. Pooled it
  11. Trial
  12. Trial
  13. Association of nutraceutical supplements with longer telomere length.International journal of molecular medicine · 2019
    Trial
  14. Trial
  15. Circulating cell-free mitochondrial DNA, but not leukocyte mitochondrial DNA copy number, is elevated in major depressive disorder.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2018
    Trial
  16. Trial
  17. Trial
  18. Trial
  19. Review
  20. Article

87 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 2 institutions in 4 countries.

Daniel LindqvistDepartment of Clinical Sciences, Section for Psychiatry, Lund University, Lund, Sweden; Department of Psychiatry, University of California San Francisco (UCSF), School of Medicine, San Francisco, CA, USA.
Elissa S EpelDepartment of Psychiatry, University of California San Francisco (UCSF), School of Medicine, San Francisco, CA, USA.
Synthia H MellonDepartment of OB-GYN and Reproductive Sciences, UCSF School of Medicine, San Francisco, CA, USA.
Brenda W PenninxDepartment of Psychiatry and EMGO Institute for Health and Care Research, VU University Medical Center, Amsterdam, The Netherlands.
Dóra RévészDepartment of Psychiatry and EMGO Institute for Health and Care Research, VU University Medical Center, Amsterdam, The Netherlands.
Josine E VerhoevenDepartment of Psychiatry and EMGO Institute for Health and Care Research, VU University Medical Center, Amsterdam, The Netherlands.
Victor I ReusDepartment of Psychiatry, University of California San Francisco (UCSF), School of Medicine, San Francisco, CA, USA.
Jue LinDepartment of Biochemistry and Biophysics, UCSF School of Medicine, San Francisco, CA, USA.
Laura MahanDepartment of Psychiatry, University of California San Francisco (UCSF), School of Medicine, San Francisco, CA, USA.
Christina M HoughDepartment of Psychiatry, University of California San Francisco (UCSF), School of Medicine, San Francisco, CA, USA.
Rebecca RosserDepartment of Psychiatry, University of California San Francisco (UCSF), School of Medicine, San Francisco, CA, USA.
F Saverio BersaniDepartment of Psychiatry, University of California San Francisco (UCSF), School of Medicine, San Francisco, CA, USA; Department of Neurology and Psychiatry, Sapienza University of Rome, Rome, Italy.
Elizabeth H BlackburnDepartment of Biochemistry and Biophysics, UCSF School of Medicine, San Francisco, CA, USA.
Owen M WolkowitzDepartment of Psychiatry, University of California San Francisco (UCSF), School of Medicine, San Francisco, CA, USA. Electronic address: Owen.Wolkowitz@ucsf.edu.
University of California, San Francisco · USAmsterdam Public Health · NL

Funding

Cell Aging in Major DepressionR01MH083784 · NIMH · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI EPEL, ELISSA S., MELLON, SYNTHIA H · 2010 to 2020
$6.7M
Chronic and Acute Psychosocial Stress and Impaired Cell AgingR01AG030424 · NIA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI EPEL, ELISSA S. · 2010 to 2014
$3.5M
Chronic and Acute Psychosocial Stress and Impaired Cell AgingR56AG030424 · NIA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI EPEL, ELISSA S. · 2008 to 2009
$260k
NIA NIH HHS 01AG030424-01A1NIA NIH HHS R01 AG030424NIMH NIH HHS R01 MH083784NIMH NIH HHS R01MH083784
6 · The paper itself

Abstract

Many psychiatric illnesses are associated with early mortality and with an increased risk of developing physical diseases that are more typically seen in the elderly. Moreover, certain psychiatric illnesses may be associated with accelerated cellular aging, evidenced by shortened leukocyte telomere length (LTL), which could underlie this association. Shortened LTL reflects a cell's mitotic history and cumulative exposure to inflammation and oxidation as well as the availability of telomerase, a telomere-lengthening enzyme. Critically short telomeres can cause cells to undergo senescence, apoptosis or genomic instability, and shorter LTL correlates with poorer health and predicts mortality. Emerging data suggest that LTL may be reduced in certain psychiatric illnesses, perhaps in proportion to exposure to the psychiatric illnesses, although conflicting data exist. Telomerase has been less well characterized in psychiatric illnesses, but a role in depression and in antidepressant and neurotrophic effects has been suggested by preclinical and clinical studies. In this article, studies on LTL and telomerase activity in psychiatric illnesses are critically reviewed, potential mediators are discussed, and future directions are suggested. A deeper understanding of cellular aging in psychiatric illnesses could lead to re-conceptualizing them as systemic illnesses with manifestations inside and outside the brain and could identify new treatment targets.

Indexed as

AdolescentAdultAgedCellular SenescenceChildFemaleHumansLeukocytesMaleMental DisordersMiddle AgedTelomereYoung AdultAgingAntidepressantAnxietyBipolar affective disorderDepressionDiseaseEarly life adversityInflammationLeukocytesMajor depressive disorderManic-depressionMortalityNeurotrophicOxidative stressPost-traumatic stress disorderPsychosisSchizophreniaStressTelomeraseTelomeres

Identifiers

PMID25999120
PMCPMC4501875
OpenAlexW1733523167

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.